Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Intangibles (2016 - 2019)

Tandem Diabetes Care filings provide 7 years of Intangibles readings, the most recent being $885000.0 for Q3 2019.

  • On a quarterly basis, Intangibles fell 26.98% to $885000.0 in Q3 2019 year-over-year; TTM through Sep 2019 was $885000.0, a 26.98% decrease, with the full-year FY2018 number at $1.1 million, down 22.44% from a year prior.
  • Intangibles hit $885000.0 in Q3 2019 for Tandem Diabetes Care, down from $967000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $3.2 million in Q4 2015 to a low of $885000.0 in Q3 2019.
  • Median Intangibles over the past 5 years was $1.6 million (2017), compared with a mean of $1.8 million.
  • Biggest five-year swings in Intangibles: skyrocketed 33.02% in 2015 and later crashed 55.13% in 2017.
  • Tandem Diabetes Care's Intangibles stood at $3.2 million in 2015, then changed by 0.0% to $3.2 million in 2016, then crashed by 55.13% to $1.5 million in 2017, then fell by 22.44% to $1.1 million in 2018, then decreased by 21.68% to $885000.0 in 2019.
  • The last three reported values for Intangibles were $885000.0 (Q3 2019), $967000.0 (Q2 2019), and $1.0 million (Q1 2019) per Business Quant data.